Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Franklin Resources Inc.

Franklin Resources Inc. lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,304,849 shares of the medical equipment provider’s stock after selling 125,766 shares during the quarter. Intuitive Surgical makes up approximately 0.6% of Franklin Resources Inc.’s holdings, making the stock its 27th biggest holding. Franklin Resources Inc.’s holdings in Intuitive Surgical were worth $2,246,958,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of ISRG. Atala Financial Inc acquired a new stake in Intuitive Surgical in the 4th quarter worth about $25,000. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Summit Securities Group LLC acquired a new stake in Intuitive Surgical during the 4th quarter valued at $30,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new position in Intuitive Surgical in the 4th quarter worth $31,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 3.2 %

NASDAQ ISRG opened at $491.84 on Monday. The company has a market cap of $175.18 billion, a P/E ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a fifty day simple moving average of $556.28 and a 200 day simple moving average of $532.97.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the completion of the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. UBS Group increased their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Raymond James increased their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Leerink Partners increased their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Royal Bank of Canada lifted their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.